Lantern Pharma INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Lantern Pharma Inc. will hold its 2025 Annual Meeting to vote on director elections, a one-time stock option repricing, auditor ratification, and meeting adjournment.
NASDAQ
Lantern Pharma is asking stockholders to approve an amendment to its equity incentive plan to increase the number of shares available for issuance by 125,000.